Skip to content

    HLE Glascoat

    HLEGLAS
    Capital Goods·23 May 2025
    Management Summary

    HLE Glascoat delivered a strong Q4 FY25, with significant year-on-year growth in revenue, EBITDA, and PAT, driven by operational efficiencies and strategic initiatives. The company also made substantial progress in debt reduction and secured a large oil and gas order through Kinam Engineering, reinforcing its diversified capabilities. While the F&D segment saw some de-growth, a robust order book for this segment is expected to drive recovery in the coming year.

    Highlights

    6
    • Q4 FY25 Revenue from operations grew 8.7% YoY to INR 334 crores.

    • Q4 FY25 EBITDA grew 41.1% YoY to INR 54 crores, with EBITDA margin at 16.3%.

    • Q4 FY25 PAT jumped 113.8% YoY to INR 32 crores, with PAT margin at 9.5%.

    • Reduced debt obligations by approximately INR 50 crores in FY25 through strong cash generation.

    • Kinam Engineering initiated supplies for its first large oil and gas order, to be fully executed in Q1 FY26, marking strategic entry into a new vertical.

    • Healthy order book provides 6-7 months of visibility for both India and international businesses.

    Concerns

    2
    • Filtration, Drying, and Other Equipment segment de-grew by 5% in Q4 FY25 and 16% in FY25.

    • Agrochemicals segment facing short-term pricing pressure.

    Key financials

    Metrics

    8

    Periods

    2

    Q4 FY25

    5
    • Revenue
      ₹334 Cr
      YoY+8.7%QoQ+44.4%
    • EBITDA
      ₹54 Cr
      YoY+41.1%QoQ+96.7%
    • EBITDA Margin
      16.3%
    • PAT
      ₹32 Cr
      YoY+113.8%QoQ+2.1%
    • PAT Margin
      9.5%

    FY25

    3
    • Revenue
      ₹1,028 Cr
      YoY+6.2%
    • EBITDA Growth
      16.6%
    • EBITDA Margin
      13.7%

    Segment breakdown

    Filtration, Drying, and Other Equipment
    ₹109 Cr Q4 FY25 Revenue-16% FY25 Revenue Growth11.2% Q4 FY25 EBIT Margin
    Glass-lined Equipment
    ₹582 Cr FY25 Sales85% Q4 FY25 EBIT Growth
    Heat Transfer Equipment
    ₹122 Cr FY25 Sales
    List

    Order Book

    high confidence

    Total Value

    ₹ 575.1 crores

    as of 2025-03-31

    quantified

    Execution

    around six months for the India business and about seven months for the international business

    Composition

    Pharma(client type)

    "Order book has increased by close to Rs. 100 crores since March 31, providing good visibility for the coming quarters."

    Source:
    Q&A

    Capital allocation

    5
    high confidence
    CategoryHeadline
    Capex

    ₹12 crores

    Debt

    Debt disclosed

    M&A

    Kinam Enterprise Private Limited

    merger · pending regulatory · Consideration ₹NaN (undisclosed)

    M&A

    Clean Max Anchorage

    joint venture · announced · Consideration ₹NaN (undisclosed)

    Liquidity

    Liquidity disclosed

    Strong cash generation during the financial year enabled debt reduction.

    Guidance & targets

    6
    CategoryTargetPriority
    Growth
    Overall Revenue Growth
    16% to 20%
    Medium
    Growth
    Thaletec Growth
    15%
    Medium
    Margin
    India GL Business Long-term Sustainable Margin
    17% to 18%
    High
    Margin
    German GL Business Long-term Sustainable Margin
    14% to 15%
    High
    Revenue
    Kinam Engineering Revenue
    Rs. 200 crores
    Medium
    Profitability
    Net Profit
    Rs. 100 crores
    Low

    F&D Segment Revenue Recovery

    Next quarter (Q1 FY26)
    CurrentDe-grew 5% in Q4 FY25 and 16% in FY25
    TargetPositive growth, reflecting strong order book conversion

    Why it matters

    This segment experienced de-growth, and its recovery is key for overall growth.

    So, the top line in the F&D business should recover this year.

    How to verify

    key_financials.segment_breakdown[name='Filtration, Drying, and Other Equipment'].metrics[label='Q4 FY25 Revenue']

    Risks & concerns

    2
    RiskSeverity

    Short-term pricing pressure in agrochemicals

    Agrochemicals segment facing short-term pricing pressure, though inventory normalization and policy support are expected to aid recovery.Management acknowledged

    medium

    Subdued demand in other chemical industry segments

    Non-pharma chemical segments (agrochemicals, dyes, colorants, pigments) have seen encouraging development but are not yet at desired levels, with expectations of revival.Management acknowledged

    medium

    Q&A highlights

    8

    “As far as the split between India and the Thaletec Germany business goes, the ThaletecGermany business has actually contributed a larger share of the growth in the overall GLE business rather than the India business.”

    Clarifies the geographic drivers of growth within the glass-lined equipment segment.

    asked by Jaiveer Shekhawat

    3 min read7 chapters

    Detailed Narrative

    01

    Q4 FY25 & FY25 Financial Performance

    HLE Glascoat delivered a strong Q4 FY25, with revenue from operations growing 8.7% YoY to INR 334 crores. EBITDA for the quarter increased by 41.1% YoY to INR 54 crores, achieving an EBITDA margin of 16.3%. Net profit for Q4 FY25 saw a significant jump of 113.8% YoY to INR 32 crores, with a PAT margin of 9.5%. For the full FY25, consolidated revenue grew 6.2% to INR 1,028 crores, and EBITDA increased by 16.6% YoY, resulting in an annual EBITDA margin of 13.7%.

    02

    Market Outlook & Strategic Initiatives

    The company observes a positive macroeconomic outlook, with India entering a multi-year CAPEX cycle driven by public and private investments. Stable demand in pharmaceuticals and expected recovery in specialty chemicals and agrochemicals (post-global trade uncertainty) are anticipated to drive growth. HLE Glascoat is strategically positioned to capitalize on these tailwinds through its robust product portfolio, long-standing customer relationships, and continuous focus on improving internal efficiencies and balance sheet optimization.

    03

    Kinam Engineering & Amalgamation Progress

    Kinam Engineering has successfully initiated supplies for its first large oil and gas order, which is expected to be fully executed in Q1 FY26. This marks a strategic entry into a high-potential vertical, diversifying HLE Glascoat's end-market exposure. Furthermore, the NCLT Ahmedabad Bench has scheduled the final hearing for the scheme of amalgamation of Kinam Enterprise Private Limited with HLE Glascoat Limited in July 2025. Upon approval, this will complete the multi-state acquisition and result in HLE Glascoat owning a 70% stake in Kinam Engineering Industries Private Limited, aiming to unlock operational synergies and enhance shareholder value.

    04

    Operational Efficiency & Balance Sheet Optimization

    HLE Glascoat demonstrated strong cash generation during FY25, which enabled the company to reduce both long-term and short-term debt obligations by approximately INR 50 crores. This aligns with the company's commitment to strengthening its balance sheet and reducing interest costs. The company maintains a healthy order book, providing over 6 months of visibility for the India business and over 7 months for the international business, supporting sustained growth.

    05

    Segmental Performance Overview

    The Glass-lined Equipment business generated FY25 sales of INR 582 crores, reflecting a 17% growth YoY, with Q4 FY25 EBIT growing 85% to INR 54 crores. The Heat Transfer Equipment business also showed strong growth, contributing INR 122 crores to FY25 sales, up 38% YoY. In contrast, the Filtration, Drying, and Other Equipment segment experienced a 5% de-growth in Q4 FY25 and a 16% de-growth for FY25, although a strong order book is expected to drive its recovery in the coming year.

    06

    R&D and Center of Excellence Investment

    HLE Glascoat has inaugurated a state-of-the-art Center of Excellence at Anand, Gujarat, dedicated to glass lining research, new product development, and advanced production techniques. This facility, while not directly increasing overall capacity, is designed to improve product quality, enhance material realization, and foster long-term innovation. It also supports joint development efforts with the Thaletec team for the Indian market, reinforcing the company's commitment to delivering innovative solutions.

    07

    Capital Expenditure and Debt Management

    The company plans for minimal maintenance CAPEX, estimated to range between INR 12 crores to INR 15 crores annually across its five plants. No major CAPEX is planned for new plants this year, as the focus remains on leveraging existing capacity, which is currently utilized at approximately 75% on a weighted average basis. The significant debt reduction of INR 50 crores in FY25, achieved through strong operational cash flows, highlights the company's disciplined financial approach and commitment to a stronger balance sheet.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.